Pasar al contenido principal

OREXINAS/HYPOCRETINAS Y MEMORIA AVERSIVA: MECANISMOS NEUROBIOLOGICOS Y UTILIDAD POTENCIAL EN MODELOS ANIMALES DE RESISTENCIA A LA EXTINCION DEL MIEDO

SAF2017-85299-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD FRANCISCO DE VITORIA (FUNDACIÓN UNIVERSIDAD FRANCISCO DE VITORIA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1

  • Ten-Blanco, Marc
  • Flores de los Heros, África, 1985-
  • Pereda-Pérez, Inmaculada
  • Piscitelli, Fabiana
  • Izquierdo-Luengo, Cristina
  • Cristino, Luigia
  • Romero, Julián
  • Hillard, Cecilia J.
  • Maldonado, Rafael, 1961-
  • Di Marzo, Vicenzo
  • Berrendero Díaz, Fernando, 1971-
Anxiety and stress disorders are often characterized by an inability to extinguish learned fear responses. Orexins/hypocretins are involved in the modulation of aversive memories, and dysregulation of this system may contribute to the aetiology of anxiety disorders characterized by pathological fear. The mechanisms by which orexins regulate fear are unknown. Here we investigated the role of the endogenous cannabinoid system in the impaired fear extinction induced by orexin-A (OXA) in male mice. The selective inhibitor of 2-arachidonoylglycerol (2-AG) biosynthesis O7460 abolished the fear extinction deficits induced by OXA. Accordingly, increased 2-AG levels were observed in the amygdala and hippocampus of mice treated with OXA that do not extinguish fear, suggesting that high levels of this endocannabinoid are related to poor extinction. Impairment of fear extinction induced by OXA was associated with increased expression of CB2 cannabinoid receptor (CB2R) in microglial cells of the basolateral amygdala. Consistently, the intra-amygdala infusion of the CB2R antagonist AM630 completely blocked the impaired extinction promoted by OXA. Microglial and CB2R expression depletion in the amygdala with PLX5622 chow also prevented these extinction deficits. These results show that overactivation of the orexin system leads to impaired fear extinction through 2-AG and amygdalar CB2R. This novel mechanism could be of relevance for the development of novel potential approaches to treat diseases associated with inappropriate retention of fear, such as post-traumatic stress disorder, panic anxiety and phobias., This work was supported by MICINN [PID2020-116579RB-100/AEI/10.13039/501100011033] and "Ministerio de Economía y Competitividad" MINECO/FEDER, UE [SAF2017-85299-R] to FB and [PID2019-108992-RB-100] to JR, "Plan Nacional sobre Drogas" [#2019I024] to FB and “Proyectos de investigación Universidad Francisco de Vitoria [2018-2019]" to FB. M.T-B and C.I-L are supported by a predoctoral fellowship from Universidad Francisco de Vitoria. Any of the funding sources were involved in the study design and preparation. We are grateful to Dr Rosa María Tolón for her guidance on RT-PCR analyses, and Dr M. Ruth Pazos and Mario Amores for their assistance with microscopy evaluation.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood

  • Saravia Santos, Rocio, 1988-
  • Ten-Blanco, Marc
  • Julià Hernández, Marina
  • Gagliano, Humberto
  • Andero, Raül
  • Armario García, Antonio
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Δ9-tetrahydrocannabinol (THC) consumption during adolescence is reported to be a risk factor for the appearance of psychiatric disorders later in life. The interaction between genetic or environmental events and cannabinoid exposure in the adolescent period can also contribute to exacerbate behavioural deficits in adulthood. Here we investigate the effects of THC treatment as well as the consequences of concomitant THC and stress exposure during adolescence in the extinction of fear memory in adult mice. Adolescent mice treated with THC and exposed to stress exhibit impaired cued fear extinction in adulthood. However, no effect was observed in animals exposed to these two factors separately. Notably, resistance to fear extinction was associated with decreased neuronal activity in the basolateral amygdala (BLA) and the infralimbic prefrontal cortex, suggesting a long-term dysregulation of the fear circuit. These changes in neuronal activation were paralleled with structural plasticity alterations. Indeed, an increase of immature dendritic spines in pyramidal neurons of the BLA was revealed in mice simultaneously exposed to THC and stress. Corticosterone levels were also enhanced after the cued fear conditioning session in the same experimental group. These results show that an interaction between cannabis exposure and stress during adolescence may lead to long-term anxiety disorders characterized by the presence of pathological fear., This work was supported by “Plan Nacional sobre Drogas” (#2014I019) and “Ministerio de Economía y Competitividad” (SAF2017-85299-R) to FB, the "Generalitat de Catalunya-AGAUR" (#2014-SGR-1547), ICREA-Acadèmia(2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM, NARSAD Young Investigator Grant #22434, Ramón y Cajal program RYC2014-15784, RETOS-MINECOSAF2016-76565-R and FEDER funds to RA, and “Ministerio de Economía y Competitividad” (SAF2014-53876R) and “Generalitat de Catalunya” (SGR 2014-1020) to AA
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice

  • Saravia Santos, Rocio, 1988-
  • Ten-Blanco, Marc
  • Grande, María T.
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Nicotine withdrawal is associated with cognitive deficits including attention, working memory, and episodic memory impairments. These cognitive deficits are a hallmark of nicotine abstinence which could be targeted in order to prevent smoking relapse. The underlying mechanisms, however, are poorly understood. In this study, memory impairment was observed in mice 4 days after the precipitation of nicotine withdrawal by the nicotinic antagonist mecamylamine. The presence of cognitive deficits correlated with microglial activation in the hippocampus and the prefrontal cortex. Moreover, an increased expression of neuroinflammatory markers including IL1β, TNFα and IFNγ was found in both memory-related brain regions. Notably, flow cytometric analysis also revealed an enhancement of TNFα and IFNγ plasmatic levels at the same time point during nicotine withdrawal. Impaired neurogenesis, as shown by reduction in the expression of the endogenous cell proliferation marker Ki67 and the early neuron marker doublecortin, was also associated with nicotine abstinence. Treatment with the non-psychoactive cannabinoid cannabidiol abolished memory impairment of nicotine withdrawal and microglia reactivity, reduced the expression of IL1β and IFNγ in the hippocampus and the prefrontal cortex, respectively, and normalized Ki67 levels. The nonsteroidal anti-inflammatory drug indomethacin also prevented cognitive deficits and microglial reactivity during withdrawal. These data underline the usefulness of anti-inflammatory agents to improve cognitive performance during early nicotine abstinence., This work was supported by “Plan Nacional sobre Drogas”(#2014I019) and “Ministerio de Economía y Competitividad” MINECO/FEDER, UE (SAF2017-85299-R) to FB, the “Generalitat deCatalunya-AGAUR” (#2014-SGR-1547), ICREA-Acadèmia (2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM. Rocio Saraviais a recipient of a predoctoral fellowship from the “Instituto de Salud Carlos III”
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

When orexins meet cannabinoids: Bidirectional functional interactions

  • Berrendero Díaz, Fernando, 1971-
  • Flores de los Heros, África, 1985-
  • Robledo, Patricia, 1958-
A growing body of evidence suggests the existence of biochemical and functional interactions between the endocannabinoid and orexin systems. Cannabinoid and orexin receptors have been shown to form heterodimers in agreement with the overlapping distribution of both receptors in several brain areas, and the activation of common intracellular signaling pathways, such as the MAP kinase cascade. The activation of orexin receptors induces the synthesis of the endocannabinoid 2-arachidonoyl glycerol suggesting that the endocannabinoid system participates in some physiological functions of orexins. Indeed, functional interactions between these two systems have been demonstrated in several behavioral responses including nociception, reward and food intake. The present review is focused on the latest developments in cannabinoid-orexin cross-modulation and the implications of this interesting interaction., This work was supported by Instituto de Salud Carlos III (PI14/00210),the Fundació la Marató de TV3 (231/C/2014) to PR,“Plan Nacional sobre Drogas”(#2014I019) and “Ministerio de Economía y Competitividad”(SAF2017-85299-R) to FB, and the Catalunya Government AGAUR (2017SGR210). We would like to thank Carla Ramón Duaso for her help with reference editing.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

THC exposure during adolescence does not modify nicotine reinforcing effects and relapse in adult male mice

  • Flores de los Heros, África, 1985-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Rationale: Cannabis use is typically initiated during adolescence, and different studies suggest that adolescent cannabinoid exposure may increase the risk for drug addiction in adulthood. Objectives: This study investigated the effects of adolescent exposure to the main psychoactive component of cannabis, ∆9-tetrahydrocannabinol (THC), in the reinforcing properties of nicotine in adult male mice. Possible alterations in relapse to nicotine-seeking behaviour in adult animals due to THC adolescent exposure were also evaluated. Methods: Adolescent mice were exposed to escalating doses of THC from PND35 to PND49. When mice reached adulthood (PND70), surgical procedures were applied for further behavioural evaluation. Nicotine self-administration sessions were conducted consecutively for 10 days. Following extinction, mice were tested for cue- and stress-induced reinstatement of nicotine-seeking behaviour. Results: Adolescent THC treatment did not modify acquisition and extinction of nicotine self-administration in adulthood. Moreover, THC exposure did not alter relapse to nicotine seeking induced by stress or nicotine-associated cues. Conclusions: These results suggest that a history of exposure to THC during adolescence under these particular conditions does not modify the reinforcing effects and seeking behaviour of nicotine in the adult period., This work was supported by “Plan Nacional sobre Drogas” (#2014I019) and “Ministerio de Economía y Competitividad” (SAF2017-85299-R) to FB, the “Generalitat de Catalunya-AGAUR” (#2014-SGR-1547), ICREA-Acadèmia (2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice

  • Saravia Santos, Rocio, 1988-
  • Ten-Blanco, Marc
  • Grande, María T.
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Nicotine withdrawal is associated with cognitive deficits including attention, working memory, and episodic memory impairments. These cognitive deficits are a hallmark of nicotine abstinence which could be targeted in order to prevent smoking relapse. The underlying mechanisms, however, are poorly understood. In this study, memory impairment was observed in mice 4 days after the precipitation of nicotine withdrawal by the nicotinic antagonist mecamylamine. The presence of cognitive deficits correlated with microglial activation in the hippocampus and the prefrontal cortex. Moreover, an increased expression of neuroinflammatory markers including IL1β, TNFα and IFNγ was found in both memory-related brain regions. Notably, flow cytometric analysis also revealed an enhancement of TNFα and IFNγ plasmatic levels at the same time point during nicotine withdrawal. Impaired neurogenesis, as shown by reduction in the expression of the endogenous cell proliferation marker Ki67 and the early neuron marker doublecortin, was also associated with nicotine abstinence. Treatment with the non-psychoactive cannabinoid cannabidiol abolished memory impairment of nicotine withdrawal and microglia reactivity, reduced the expression of IL1β and IFNγ in the hippocampus and the prefrontal cortex, respectively, and normalized Ki67 levels. The nonsteroidal anti-inflammatory drug indomethacin also prevented cognitive deficits and microglial reactivity during withdrawal. These data underline the usefulness of anti-inflammatory agents to improve cognitive performance during early nicotine abstinence., This work was supported by “Plan Nacional sobre Drogas”(#2014I019) and “Ministerio de Economía y Competitividad” MINECO/FEDER, UE (SAF2017-85299-R) to FB, the “Generalitat deCatalunya-AGAUR” (#2014-SGR-1547), ICREA-Acadèmia (2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM. Rocio Saraviais a recipient of a predoctoral fellowship from the “Instituto de Salud Carlos III”
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

THC exposure during adolescence does not modify nicotine reinforcing effects and relapse in adult male mice

  • Flores de los Heros, África, 1985-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Rationale: Cannabis use is typically initiated during adolescence, and different studies suggest that adolescent cannabinoid exposure may increase the risk for drug addiction in adulthood. Objectives: This study investigated the effects of adolescent exposure to the main psychoactive component of cannabis, ∆9-tetrahydrocannabinol (THC), in the reinforcing properties of nicotine in adult male mice. Possible alterations in relapse to nicotine-seeking behaviour in adult animals due to THC adolescent exposure were also evaluated. Methods: Adolescent mice were exposed to escalating doses of THC from PND35 to PND49. When mice reached adulthood (PND70), surgical procedures were applied for further behavioural evaluation. Nicotine self-administration sessions were conducted consecutively for 10 days. Following extinction, mice were tested for cue- and stress-induced reinstatement of nicotine-seeking behaviour. Results: Adolescent THC treatment did not modify acquisition and extinction of nicotine self-administration in adulthood. Moreover, THC exposure did not alter relapse to nicotine seeking induced by stress or nicotine-associated cues. Conclusions: These results suggest that a history of exposure to THC during adolescence under these particular conditions does not modify the reinforcing effects and seeking behaviour of nicotine in the adult period., This work was supported by “Plan Nacional sobre Drogas” (#2014I019) and “Ministerio de Economía y Competitividad” (SAF2017-85299-R) to FB, the “Generalitat de Catalunya-AGAUR” (#2014-SGR-1547), ICREA-Acadèmia (2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood

  • Saravia Santos, Rocio, 1988-
  • Ten-Blanco, Marc
  • Julià Hernández, Marina
  • Gagliano, Humberto
  • Andero, Raül
  • Armario García, Antonio
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Δ9-tetrahydrocannabinol (THC) consumption during adolescence is reported to be a risk factor for the appearance of psychiatric disorders later in life. The interaction between genetic or environmental events and cannabinoid exposure in the adolescent period can also contribute to exacerbate behavioural deficits in adulthood. Here we investigate the effects of THC treatment as well as the consequences of concomitant THC and stress exposure during adolescence in the extinction of fear memory in adult mice. Adolescent mice treated with THC and exposed to stress exhibit impaired cued fear extinction in adulthood. However, no effect was observed in animals exposed to these two factors separately. Notably, resistance to fear extinction was associated with decreased neuronal activity in the basolateral amygdala (BLA) and the infralimbic prefrontal cortex, suggesting a long-term dysregulation of the fear circuit. These changes in neuronal activation were paralleled with structural plasticity alterations. Indeed, an increase of immature dendritic spines in pyramidal neurons of the BLA was revealed in mice simultaneously exposed to THC and stress. Corticosterone levels were also enhanced after the cued fear conditioning session in the same experimental group. These results show that an interaction between cannabis exposure and stress during adolescence may lead to long-term anxiety disorders characterized by the presence of pathological fear., This work was supported by “Plan Nacional sobre Drogas” (#2014I019) and “Ministerio de Economía y Competitividad” (SAF2017-85299-R) to FB, the "Generalitat de Catalunya-AGAUR" (#2014-SGR-1547), ICREA-Acadèmia(2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM, NARSAD Young Investigator Grant #22434, Ramón y Cajal program RYC2014-15784, RETOS-MINECOSAF2016-76565-R and FEDER funds to RA, and “Ministerio de Economía y Competitividad” (SAF2014-53876R) and “Generalitat de Catalunya” (SGR 2014-1020) to AA
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1

  • Ten-Blanco, Marc
  • Flores de los Heros, África, 1985-
  • Pereda-Pérez, Inmaculada
  • Piscitelli, Fabiana
  • Izquierdo-Luengo, Cristina
  • Cristino, Luigia
  • Romero, Julián
  • Hillard, Cecilia J.
  • Maldonado, Rafael, 1961-
  • Di Marzo, Vicenzo
  • Berrendero Díaz, Fernando, 1971-
Anxiety and stress disorders are often characterized by an inability to extinguish learned fear responses. Orexins/hypocretins are involved in the modulation of aversive memories, and dysregulation of this system may contribute to the aetiology of anxiety disorders characterized by pathological fear. The mechanisms by which orexins regulate fear are unknown. Here we investigated the role of the endogenous cannabinoid system in the impaired fear extinction induced by orexin-A (OXA) in male mice. The selective inhibitor of 2-arachidonoylglycerol (2-AG) biosynthesis O7460 abolished the fear extinction deficits induced by OXA. Accordingly, increased 2-AG levels were observed in the amygdala and hippocampus of mice treated with OXA that do not extinguish fear, suggesting that high levels of this endocannabinoid are related to poor extinction. Impairment of fear extinction induced by OXA was associated with increased expression of CB2 cannabinoid receptor (CB2R) in microglial cells of the basolateral amygdala. Consistently, the intra-amygdala infusion of the CB2R antagonist AM630 completely blocked the impaired extinction promoted by OXA. Microglial and CB2R expression depletion in the amygdala with PLX5622 chow also prevented these extinction deficits. These results show that overactivation of the orexin system leads to impaired fear extinction through 2-AG and amygdalar CB2R. This novel mechanism could be of relevance for the development of novel potential approaches to treat diseases associated with inappropriate retention of fear, such as post-traumatic stress disorder, panic anxiety and phobias., This work was supported by MICINN [PID2020-116579RB-100/AEI/10.13039/501100011033] and "Ministerio de Economía y Competitividad" MINECO/FEDER, UE [SAF2017-85299-R] to FB and [PID2019-108992-RB-100] to JR, "Plan Nacional sobre Drogas" [#2019I024] to FB and “Proyectos de investigación Universidad Francisco de Vitoria [2018-2019]" to FB. M.T-B and C.I-L are supported by a predoctoral fellowship from Universidad Francisco de Vitoria. Any of the funding sources were involved in the study design and preparation. We are grateful to Dr Rosa María Tolón for her guidance on RT-PCR analyses, and Dr M. Ruth Pazos and Mario Amores for their assistance with microscopy evaluation.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

When orexins meet cannabinoids: Bidirectional functional interactions

  • Berrendero Díaz, Fernando, 1971-
  • Flores de los Heros, África, 1985-
  • Robledo, Patricia, 1958-
A growing body of evidence suggests the existence of biochemical and functional interactions between the endocannabinoid and orexin systems. Cannabinoid and orexin receptors have been shown to form heterodimers in agreement with the overlapping distribution of both receptors in several brain areas, and the activation of common intracellular signaling pathways, such as the MAP kinase cascade. The activation of orexin receptors induces the synthesis of the endocannabinoid 2-arachidonoyl glycerol suggesting that the endocannabinoid system participates in some physiological functions of orexins. Indeed, functional interactions between these two systems have been demonstrated in several behavioral responses including nociception, reward and food intake. The present review is focused on the latest developments in cannabinoid-orexin cross-modulation and the implications of this interesting interaction., This work was supported by Instituto de Salud Carlos III (PI14/00210),the Fundació la Marató de TV3 (231/C/2014) to PR,“Plan Nacional sobre Drogas”(#2014I019) and “Ministerio de Economía y Competitividad”(SAF2017-85299-R) to FB, and the Catalunya Government AGAUR (2017SGR210). We would like to thank Carla Ramón Duaso for her help with reference editing.